Download Alphabet App Get Offers 5
Download Alphabet AppGet Offers
5 • Download App for exclusive offers
IngredientsCheck your order
Việt Nam
English
CÔNG TY TNHH THƯƠNG MẠI DỊCH VỤ ALPHABET
0
Your shopping cart is empty!
Staclazide 30mg MR (6 blisters x 10 tablets/box)
Brand: STELLAProduct Code: A577788028In Stock

Staclazide 30mg MR (6 blisters x 10 tablets/box)

8 reviewsWrite a review Kiểm duyệt chuyên môn

Staclazide 30 MR contains gliclazide, a type 2 antidiabetic (non-insulin-dependent diabetes mellitus), sulfonylurea, taken orally. Gliclazide is effective only in patients whose pancreas still operate (capable of producing insulin). Staclazide 30 MR is usually indicated as an adjunct to diet, exercise; it is used single or in combination with other hypoglycemia drugs such as metformin, insulin.

This product requires pharmacist consultation
Complying with medical pharmaceutical distribution regulations
This product requires advice from a professional pharmacist before use. Self-service online ordering is not supported.
100% Genuine MedicineGPP Ministry of Health standard
24/7 Pharmacist ConsultationHigh expertise, dedicated, correct dose
Express DeliveryFast, proper medicine storage
Convenient ReturnsProtecting patient rights
Share: Facebook Zalo

Indications

Diabetic non-insulin-dependent (type 2) in adults.


Contraindications

Known hypersensitivity to any of the active substance or excipients.

Patients with type 1 diabetes.

Diabetic pre-coma and coma, diabetic keto-acidosis.

Severe infections or trauma, or major surgery.

Severe renal or hepatic insufficiency.

Treatment with miconazole.

Lactation.


Compositon/Ingredients

Gliclazide 30mg

Dosage and administration

  • The initial dose is 30 mg, once daily. If blood glucose is effectively controlled, this dose may be used for maintenance treatment. If blood glucose is not adequately controlled, the dose may be increased to 60 mg (2 tablets), 90 mg (3 tablets), 120 mg (4 tablets) daily, in successive steps, the interval between each dose increment should be at least 1 month (in patients whose blood glucose has not reduced after two weeks of treatment, the dose may be increased at the end of the second week of treatment. Gliclazide can be given in combination with metformin, α-glucosidase inhibitors (e.g. acarbose) or insulin (under close monitoring).
  • When switching from a hypoglycaemic sulfonylurea with a prolonged half-life, a treatment free period of a few days may be necessary to avoid an additive effect of the two products, which might cause hypoglycaemia.

Precaution

Sulfonylureas should be used with caution in patients with G6PD deficiency.

In patients with mild to moderate renal insufficiency.

Gliclazide should not be used in pregnant women.

The safety and efficacy of Staclazide 30 MR in children and adolescents have not been established.

Patients should be aware of how they react to drug before driving or operating machinery. They should be counselled in appropriate management of the situation of hypoglycaemic attacks while driving (stopping driving as soon as it is safe to do so, taking carbohydrate immediately, and quitting the driving seat and removing the ignition key from the car). Patients who have lost hypoglycaemic awareness, or have frequent hypoglycaemic episodes, should not drive.


Storage

Store at temperature below 30°C, protect from light.

Ask a question about this product



Write a review

Share your real experience using this product

Log in to write a review

Only customers who have purchased this product at Alphabet Pharma can submit a verified review.

Log in now
Staclazide 30mg MR (6 blisters x 10 tablets/box)

Staclazide 30mg MR (6 blisters x 10 tablets/box)

Contact Pharmacist